Antidepressant Fill and Dose Trajectories in Pregnant Women with Depression and/or Anxiety: A Norwegian Registry Linkage Study

References

• Sheffield JS, Siegel D, Mirochnick M., et al. Designing Drug Trials: considerations for Pregnant Women. Clin Infect Dis. 2014;59(suppl_7):S437–44. doi:10.1093/cid/ciu709
   Web of Science ®Google Scholar
• Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106(2):86–94. doi:10.1111/j.1742-7843.2009.00494.x
   PubMed Web of Science ®Google Scholar
• Zoega H, Kieler H, Nørgaard M, et al. Use of SSRI and SNRI Antidepressants during Pregnancy: a Population-Based Study from Denmark, Iceland, Norway and Sweden. PLoS One. 2015;10(12):e0144474. doi:10.1371/journal.pone.0144474
   PubMed Web of Science ®Google Scholar
• Petersen I, Gilbert RE, Evans SJW, Man SL, Nazareth I. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry. 2011;72(7):979–985. doi:10.4088/JCP.10m06090blu
   Web of Science ®Google Scholar
• Alwan S, Reefhuis J, Rasmussen SA, Friedman JM. National Birth Defects Prevention Study. Patterns of Antidepressant Medication Use Among Pregnant Women in a United States Population. J Clin Pharmacol. 2011;51(2):264–270. doi:10.1177/0091270010373928
   Web of Science ®Google Scholar
• Munk-Olsen T, Gasse C, Laursen TM. Prevalence of antidepressant use and contacts with psychiatrists and psychologists in pregnant and postpartum women: treatment in primary healthcare settings. Acta Psychiatr Scand. 2012;125(4):318–324. doi:10.1111/j.1600-0447.2011.01784.x
   PubMed Web of Science ®Google Scholar
• Ververs T, Kaasenbrood H, Visser G, Schobben F, Egberts T. Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol. 2006;62(10):863–870. doi:10.1007/s00228-006-0177-0
   PubMed Web of Science ®Google Scholar
• Bérard A, Sheehy O, Zhao JP, et al. Impact of antidepressant use, discontinuation, and dosage modification on maternal depression during pregnancy. Eur Neuropsychopharmacol. 2019;29(7):803–812. doi:10.1016/j.euroneuro.2019.06.007
   Web of Science ®Google Scholar
• Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295(5):499–507. doi:10.1001/jama.295.5.499
   PubMed Web of Science ®Google Scholar
• Liu X, Molenaar N, Agerbo E, et al. Antidepressant discontinuation before or during pregnancy and risk of psychiatric emergency in Denmark: a population-based propensity score-matched cohort study. PLoS Med. 2022;19(1):e1003895. doi:10.1371/journal.pmed.1003895
   Google Scholar
• Walton GD, Ross LE, Stewart DE, Grigoriadis S, Dennis CL, Vigod S. Decisional conflict among women considering antidepressant medication use in pregnancy. Arch Womens Ment Health. 2014;17(6):493–501. doi:10.1007/s00737-014-0448-1
   PubMed Web of Science ®Google Scholar
• Ramos É, St-André M, Rey É, Oraichi D, Bérard A. Duration of antidepressant use during pregnancy and risk of major congenital malformations. Br J Psychiatry. 2008;192(5):344–350. doi:10.1192/bjp.bp.107.042523
   PubMed Web of Science ®Google Scholar
• Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565–574. doi:10.1002/pds.1230
   PubMed Web of Science ®Google Scholar
• Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11(7):449–457.
   PubMed Web of Science ®Google Scholar
• Østergaard K, Hallas J, Bak S, Gaist D. Long-term use of antiplatelet drugs by stroke patients: a follow-up study based on prescription register data. Eur J Clin Pharmacol. 2012;68(12):1631–1637. doi:10.1007/s00228-012-1293-7
   PubMed Web of Science ®Google Scholar
• Tanskanen A, Taipale H, Koponen M, et al. From prescription drug purchases to drug use periods – a second generation method (PRE2DUP). BMC Med Inform Decis Mak. 2015;15:21. doi:10.1186/s12911-015-0140-z
   PubMed Web of Science ®Google Scholar
• Forsman J, Taipale H, Masterman T, Tiihonen J, Tanskanen A. Comparison of dispensed medications and forensic-toxicological findings to assess pharmacotherapy in the Swedish population 2006 to 2013. Pharmacoepidemiol Drug Saf. 2018;27(10):1112–1122. doi:10.1002/pds.4426
   Web of Science ®Google Scholar
• Taipale H, Puranen A, Mittendorfer-Rutz E, et al. Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences. Nord J Psychiatry. 2020;17:1–8.
   Google Scholar
• Furu K, Strøm H, Rønning M, Skurtveit S, Engedal A, Tverdal A. The Norwegian Prescription Database (NorPD): new register for pharmacoepidemiological research covering a whole nation. Pharmacoepidemiol Drug Saf. 2005;14(Suppl. 2):S48.
   Google Scholar
• Irgens LM. The Medical Birth Registry of Norway. Acta Obstet Gynecol Scand. 2000;79(6):435–439.
   PubMed Web of Science ®Google Scholar
• Langhoff-Roos J, Krebs L, Klungsøyr K, et al. The Nordic medical birth registers--A potential goldmine for clinical research. Acta Obstet Gynecol Scand. 2014;93(2):132–137. doi:10.1111/aogs.12302
   Web of Science ®Google Scholar
• Bandoli G, Kuo GM, Sugathan R, Chambers CD, Rolland M, Palmsten K. Longitudinal trajectories of antidepressant use in pregnancy and the postnatal period. Arch Womens Ment Health. 2018;21(4):411–419. doi:10.1007/s00737-018-0809-2
   PubMed Web of Science ®Google Scholar
• Trinh NTH, Nordeng HME, Bandoli G, Eberhard-Gran M, Lupattelli A. Antidepressant and mental health care utilization in pregnant women with depression and/or anxiety: an interrupted time-series analysis. J Affect Disord. 2022;21(308):458–465. doi:10.1016/j.jad.2022.04.101
   Web of Science ®Google Scholar
• Hayasaka Y, Purgato M, Magni LR, et al. Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord. 2015;180:179–184. doi:10.1016/j.jad.2015.03.021
   PubMed Web of Science ®Google Scholar
• Bateman BT, Mhyre JM, Hernandez-Diaz S, et al. Development of a comorbidity index for use in obstetric patients. Obstet Gynecol. 2013;122(5):957–965. doi:10.1097/AOG.0b013e3182a603bb
   PubMed Web of Science ®Google Scholar
• Payne JL, Meltzer-Brody S. Antidepressant Use During Pregnancy: current Controversies and Treatment Strategies. Clin Obstet Gynecol. 2009;52(3):469–482. doi:10.1097/GRF.0b013e3181b52e20
   PubMed Web of Science ®Google Scholar
• Swanson SA, Hernandez-Diaz S, Palmsten K, Mogun H, Olfson M, Huybrechts KF. Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data. Pharmacoepidemiol Drug Saf. 2015;24(9):934–942. doi:10.1002/pds.3798
   Web of Science ®Google Scholar
• Silverman ME, Reichenberg A, Savitz DA, et al. The risk factors for postpartum depression: a population-based study. Depress Anxiety. 2017;34(2):178–187. doi:10.1002/da.22597
   PubMed Web of Science ®Google Scholar
• Genolini C, Falissard B. Kml: a package to cluster longitudinal data. Comput Methods Programs Biomed. 2011;104(3):e112–21. doi:10.1016/j.cmpb.2011.05.008
   PubMed Web of Science ®Google Scholar
• Wood ME, Lupattelli A, Palmsten K, et al. Longitudinal Methods for Modeling Exposures in Pharmacoepidemiologic Studies in Pregnancy. Epidemiol Rev. 2021;1;mxab002.
   Google Scholar
• Lupattelli A, Wood ME, Nordeng H. Analyzing Missing Data in Perinatal Pharmacoepidemiology Research: methodological Considerations to Limit the Risk of Bias. Clin Ther. 2019;41(12):2477–2487. doi:10.1016/j.clinthera.2019.11.003
   Web of Science ®Google Scholar
• Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry. 2019;6(7):601–609. doi:10.1016/S2215-0366(19)30217-2
   PubMed Web of Science ®Google Scholar
• Sit DK, Perel JM, Helsel JC, Wisner KL. Changes in Antidepressant Metabolism and Dosing Across Pregnancy and Early Postpartum. J Clin Psychiatry. 2008;69(4):652–658. doi:10.4088/JCP.v69n0419
   PubMed Web of Science ®Google Scholar
• Frank AS, Lupattelli A, Matteson DS, Nordeng H. Maternal use of thyroid hormone replacement therapy before, during, and after pregnancy: agreement between self-report and prescription records and group-based trajectory modeling of prescription patterns. Clin Epidemiol. 2018;10:1801–1816. doi:10.2147/CLEP.S175616
   Web of Science ®Google Scholar
• Cabaillot A, Bourset A, Mulliez A, et al. Trajectories of antidepressant drugs during pregnancy: a cohort study from a community‐based sample. Br J Clin Pharmacol. 2020;4:bcp.14449.
   Google Scholar
• Steen TB, Eberhard-Gran M, Nordeng H, Nerum H, Lyng S Mental health during pregnancy. Available from: https://www.legeforeningen.no/foreningsledd/fagmed/norsk-gynekologisk-forening/veiledere/veileder-i-fodselshjelp/mental-helse-i-svangerskapet/. Accessed November 4, 2022.
   Google Scholar
• Kittel-Schneider S, Felice E, Buhagiar R. Treatment of Peripartum Depression with Antidepressants and Other Psychotropic Medications: a Synthesis of Clinical Practice Guidelines in Europe. Int J Environ Res Public Health. 2022;19(4):1973. doi:10.3390/ijerph19041973
   Web of Science ®Google Scholar
• Motrico E, Moreno-Peral P, Uriko K, et al. Clinical practice guidelines with recommendations for peripartum depression: a European systematic review. Acta Psychiatr Scand. 2022;146(4):325–339. doi:10.1111/acps.13478
   Web of Science ®Google Scholar
• Bandoli G, Chambers CD, Wells A, Palmsten K. Prenatal Antidepressant Use and Risk of Adverse Neonatal Outcomes. Pediatrics. 2020;146(1):e20192493. doi:10.1542/peds.2019-2493
   PubMed Web of Science ®Google Scholar
• Skurtveit S, Selmer R, Tverdal A, Furu K, Nystad W, Handal M. Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations. J Clin Epidemiol. 2013;66(9):964–972. doi:10.1016/j.jclinepi.2013.02.011
   Web of Science ®Google Scholar